Home » FDA Funds Pediatric Trial Testing Reprogrammed HSV to Treat Cancer
FDA Funds Pediatric Trial Testing Reprogrammed HSV to Treat Cancer
A clinical trial testing a genetically reprogrammed herpes simplex virus as treatment for deadly forms of childhood cancer has received a U.S. Food and Drug Administration grant to support the research.
FirstScience
FirstScience
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May